The last quarterly stated that the 2.0 software was only live to customers 6 weeks before the release and sales were restricted before and during the roll out of the new platform which means only 2 weeks of revenue from clients in the last Quarter. Its also says that that since releasing the new software platfIorm they have made signifIcant progress intergrating the tech to companies like SILA and Scharff.
In the Dec quarter of 2017 revenue was 140000 without revenue from the new major clients so you'd have to think revenue for this quarter would have to be significantly larger then the 65000 last quarter.
I think patients is the key with this stock right now and the next quarterly will better show the revenue capabilities of this company.
YOJ Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)